Organotin(IV) Complexes as Chemotherapeutic Drugs Against Different Types of Cancer Cell Lines: A Review
DOI:
https://doi.org/10.22401/vzk9yg28Keywords:
Organotin(IV) , Cancer cell , Line cytotoxicity , ChemotherapyAbstract
Recently, organotin(IV) complexes have shown high anticancer activity against various cancer cell lines. They are promising anticancer drugs since they selectively target cancer cells. Complexes' apoptosis and caspase activities are based on alkyl or aryl groups and the anionic groups in ligands that bind to the metal. Many types of research concentrated on synthesizing different di and tri-organotin complexes using a non-aqueous medium because of its ability to hydrolyze in aqueous solutions. This current work highlights the continuing attempts to synthesize novel organotin complexes using different ligands and evaluate the cytotoxicity against the different cell lines.
References
Sinha T.; “Tumors: Benign and Malignant”. Canc. Ther. & Onco.Inte. J., 10(3):555790, 2018.
Patel A.; "Benign vs. Malignant Tumors", JAMA Oncol., 6(9):1488, 2020.
Lee Y.; Jee W.H.; Whang Y. S.; Jung C. K.; Chung Y.G.; Lee S.Y.; "Benign versus Malignant Soft-Tissue Tumors: Differentiation with 3T Magnetic Resonance Image Textural Analysis Including Diffusion-Weighted Imaging". Inves. Mag. Res. Imag., 25(2): 118-128, 2021.
Ali M. and Yousif E.; "Chemistry and Applications of Organotin(IV) Complexes: A Review". Research J. Pharm, Bio., Chem., 7(5):2611-2617, 2017.
Iqbal H.; Ali S. and Shahzadi S.; "Antituberculosis study of organotin(IV) complexes: A review". Cog. Chem., 1:1029039, 2015.
Ghazi D.; Rasheed Z. and Yousif E.; "A Review of Organotin Compounds: Chemistry and Applications". Arch. Org. Inorg. Chem. Sci., 3(3):344-352, 2018.
Jimaa R.B. and Al-Zinkee J. M.; "A Review On Organotin(IV) Thiosemicarbazone Complexes, Synthesis, Characterization and Biological Activity". J. Uni. Anbar Pure Sci., 15(2):66–73, 2021.
Hadi A. G.; Jawad K..; Ahmed D. S. and Yousif E.; "Synthesis and Biological Activities of Organotin (IV) Carboxylates: A Review". Sys. Rev. Pharm., 10(1): 26-31, 2019.
Sunday A.O.; Alafara B. Ab. and Oladele O. G.; "Toxicity and Speciation Analysis of Organotin Compounds". Chem. Spec. Bioav., 24(4): 216-226, 2012.
Graisa Ab. M.; Zainulabdeen Kh.; Salman I.; Al-Ani A.; Mohammed R.; Hairunisa N.; Mohammed S. and Yousif E.; "Toxicity and Anti-tumour Activity of Organotin(IV) Compounds". Bagh. J. Biochem. App. Biolog. Sci., 3(2):99-108, 2022.
Hoch M.; "Organotin Compounds in the Environment- An Overview, Applied Chemistry". App. Geochem., 16:719-743, 2001.
Okoro H. K.; Fatoki O. S.; Adekola F. A.; Ximba B. J. and Snyman R. G.; "Environmental Levels and Toxicity of Organotin in Marine Environment-A Review". Asian J. Chem., 23(2):473-482, 2011.
Annuar Sh. N.; Kamaludin N. F.; Awang N. and Chan K. M.; "Cellular Basis of Organotin(IV)] Derivatives as Anticancer Metallodrugs: A Review". Fron. Chem., 9:657599, 2021.
Tabassum S. and Pettinari C.; "Chemical and Biotechnological Developments in Organotin Cancer Chemotherapy". J. Organom. Chem., 691:1761–1766, 2006.
Kumar M.; Abbas Z.; Tuli H. S. and Rani A.; "Organotin Complexes with Promising Therapeutic Potential". Current Pharm. Rep., 6:167–181, 2020.
Ullah H.; Previtali V.; Mihigo H. B.; Twamley B.; Rauf M. Kh.; Javed F.; Waseem A., Baker R. J. and Rozas I.; "Structure-Activity Relationships of New Organotin(IV) Anticancer Agents and Their Cytotoxicity Profile on HL-60, MCF-7 and HeLa Human Cancer Cell Lines". Eur. J. Med. Chem., 181:111544, 2019.
Heryc E. C.; Surowsk O.; Heryc R.; Serwin N.; S. N. and Balinska B.; "Are antioxidant enzymes essential markers in the diagnosis and monitoring of cancer patients – A review". Clin. Biochem., 3(8):1-8, 2021.
Obeng E.; “ Apoptosis (Programmed Cell Death) and its Signals - A Review”. Brazilian J. Bio., 81(4):1133-1143, 2021
Elmore S.; "Apoptosis: A Review of Programmed Cell Death". Toxi. Patho., 35:495–516, 2007.
Wu J.; Ye J.; Kong W.; Zhang Sh. and Zheng Y.; "Programmed cell death pathways in hearing loss: A review of apoptosis, autophagy and programmed necrosis". Cell Prol., 53:e12915, 2020.
Tsuchiya K..; "Inflammasome‐Associated Cell Death: Pyroptosis, Apoptosis, and Physiological Implications". Microbio. Immun., 64:252–269, 2020.
Agiorgiti M. S.; Evangelou A.; Vezyrak P.; Hadjikakou S. K.; Kalfakakou V.; Tsanaktsidis I.; Batistatou A.; Zelovitis J.; Simos Y.; Ragos V.; Karkabounas S. and Peschos D.; "Cyto. Eff., Antitumour Activity and Toxicity of Organotin Derivatives with ortho- or para-Hydroxy-benzoic Acids". Med. Chem. Res., 27:1122–1130, 2018.
Haezam F. N.; Awang N.; Kamaludin N. F. and Mohamad R.; "Synthesis and Cytotoxic Activity of Organotin(IV) Diallyldithiocarbamate Compounds as Anticancer Agent Towards Colon Adenocarcinoma cells (HT-29)". Saudi J. Biolog. Sci., 28:3160–3168, 2021.
Adeyemi J. O.; Onwudiwe D. C.; Nundkumar N. and Singh M.; "Diorganotin(IV) Benzyldithiocarbamate Complexes: Synthesis, Characterization, and Thermal and Cytotoxicity Study". Open Chem., 18:453–462, 2020.
Bhaskara C.; Elangovanb N.; Sowrirajanb S.; Chandrasekarb S.; Alomard S. Y. and Nawaze A.; "Crystal Structure, Hirshfeld Surface Analysis, and Computational Study of Tin(IV) Complex: Insights from Spectroscopic, Anticancer and Cytotoxic properties". Res. Chem., 6: 101036, 2023.
Mohammed A., Makia R., Ali M., Raheem R. and Yousif E.; "Cytotoxic Effects of Valsartan Organotin(IV) Complexes on Human Lung Cancer Cells". Bio. Res. App. Chem., 11(1):8156–8164, 2021.
Panteli N. Ð.; Božic B.; Zmejkovski B.; Banjac N. R.; Dojcinovic B.; Wessjohann A. and Kaluderovic G. N.; "In vitro Evaluation of Antiproliferative Properties of Novel Organotin(IV) Carboxylate Compounds with Propanoic Acid Derivatives on a Panel of Human Cancer Cell Lines". Molecules, 26:3199, 2021.
Adeyemi J. O. and Onwudiwe D. C.; "Antimicrobial and Cytotoxicity Studies of Some Organotin(IV) N-Ethyl-N-phenyl Dithiocarbamate Complexes". Polish J. Envir. Stud., 29(4) :1-8, 2020.
Kamaludin N. F.; Ismail N.; Awang N.; Mohamad R. and Pim U.; "Cytotoxicity Evaluation and the Mode of Cell Death of K562 Cells Induced by Organotin(IV) (2-Methoxyethyl) Methyldithiocarbamate Compounds". J. Appl. Pharm. Sci., 9(6): 010-015, 2019.
Predarska I.; Saoud M.; Morgan I.; Lönnecke P.; Kaluderovic G. N. and Hey-Hawkins E.; "Triphenyltin(IV) Carboxylates with Exceptionally High Cytotoxicity against Different Breast Cancer Cell Lines". Biomolecules, 13: 595, 2023.
Ibadi F.; Yousif E. and Al-Mashhadani M.; "Recent Studies of Cancer Cell's Inhibition by Organotin (IV) Materials: An Overview". ANJS, 26(2): 23-29, 2023.
Erfan A.; Yousif E.; Alshanon A.; Ahmed D.; Bufaroosha M. and El-Hiti G.; "Organotin(IV) Complexes as Promising Potential Drug Candidates in the Field of Cancer Chemotherapy: A Narrative Review". Al-Rafidain J. Med. Sci., 5:50-56, 2023.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Abeer Erfan, Emad Yousif, Ahmed Alshanon, Gamal El-Hiti
This work is licensed under a Creative Commons Attribution 4.0 International License.
.jpg)
